Impact Factor
3.06
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.61
72 total citations
h5-index
13
h5 depth signal
Cited share
89.3%
25 of 28
Total citations
72
Citation footprint
Metric signal
3.11
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
132
Italy
15
United Kingdom
10
India
7
Australia
5
Citing Fields of Research
Brain Imaging
113
Oncology
72
Brain Neurological Disorders
69
Musculoskeletal & Nerve Cancer
19
Lymphomas
14
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
413
Articles tracked across the journal lifetime
Indexed publication set
28
25 cited publications
Last 12 months
9
1.3 publications/month
Open access share
100.0%
9 OA publications in the last year
Leading citing country
United States
132 citing publications
Leading citing field
Brain Imaging
113 citing publications
Latest tracked publication
14 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Sept. 2012-
v1n1, Sept. 2012- ; selected citations only before this date
Active Coverage
Research Focus & Classification
Indexed Subjects
Brain Imaging
Brain Neurological Disorders
Oncology
Cancer, Autophagy & Apoptosis
Lung Cancer
Broad Categories
Neoplasms
Brain Imaging
Lymphomas
MeSH Descriptors
Nervous System Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1080/20450907.2026.2711620
Open DOI
Practical management of BRAF inhibitors in glioma: toxicity and resistance
1. Breakthroughs in brain cancer therapies have been limited over the past 20 years, despite significant advances for small molecule inhibitors and immunotherapy in other solid tumors. The notable ...
03
DOI 10.1080/20450907.2026.2685339
Open DOI
Predictive value of EGFR amplification and EGFRvIII mutation in EGFR-targeted therapy for recurrent glioblastoma: a systematic review
Glioblastoma (GBM) is the most aggressive and biologically heterogeneous tumor of the central nervous system, associated with dismal prognosis and frequent recurrence. Amplification of the epidermal growth factor receptor (EGFR) and EGFR...
04
DOI 10.1080/20450907.2026.2668323
Open DOI
Tailored management of a melanoma patient with bleeding brain metastases and deep vein thrombosis with thrombectomy
We describe a 62-year-old man with disseminated melanoma (initially staged pT2aN0M0, AJCC stage IB, 8th edition AJCC) who developed multiple brain metastases with hemorrhagic transformation, pulmonary embolism, retrobulbar progression wi...
05
DOI 10.1080/20450907.2026.2666026
Open DOI
Arginine deprivation induces prolonged autophagy activation and ROS-dependent cell death in glioblastoma multiforme
Arginine deprivation was shown to be selectively cytotoxic to GBM cells with cell death being caspase-independent, non-apoptotic. In this study, we assess the impact of prolonged arginine deprivation on GBM cells, the potential activatio...
06
DOI 10.1080/20450907.2026.2641996
Open DOI
Diffuse pediatric-type high grade glioma, RTK1 subtype, subclass C with SYN2 :: PPARG fusion in an older adult
Diffuse pediatric-type high-grade glioma (pHGG), RTK1 subtype, is an uncommon aggressive tumor affecting both children and adults. We describe the case of a 66-year-old woman who presented with a left frontal lobe mass. Following surgica...
07
DOI 10.1080/20450907.2026.2626299
Open DOI
Synchronous diagnosis of multicentric glioma with distinct isocitrate dehydrogenase molecular profiles: a case report
This case report characterizes the molecular pathology of two synchronous IDH mutant gliomas in a 28-year-old female patient. The patient exhibited symptoms of dizziness, retro-orbital pain, headache, and numbness with paresthesia in her...
08
DOI 10.1080/20450907.2025.2584958
Open DOI
Impact of radiation fractionation on pseudoprogression in older patients with glioblastoma: a retrospective cohort study
We aimed to investigate a potential association between hypofractionated radiotherapy (HFRT) vs. conventional radiotherapy (CRT) and development of pseudoprogression in patients over the age of 65 treated for glioblastoma (GBM). Seventy-...
09
DOI 10.1080/20450907.2025.2571341
Open DOI
Surgical decision making in the era of supramarginal glioma resections: a current perspective and narrative review
Whether to surgically resect a margin of grossly normal appearing brain around anatomically amenable diffuse gliomas (i.e., perform a supratotal, supramarginal, or supramaximal resection) has been controversial. Over the past 5-10 years,...
10
DOI 10.1080/20450907.2025.2558455
Open DOI
Sustained response to larotrectinib in a pediatric patient with recurrent STRN3::NTRK2 fusion-positive pilocytic astrocytoma
A 7-year-old female with recurrent midline pilocytic astrocytoma harboring a rare STRN3::NTRK2 fusion achieved sustained near-complete radiographic and clinical response to larotrectinib, a selective TRK inhibitor. Initial subtotal resec...
Bibliographical & Catalog Notes
Print issues ceased with v.6, no. 4 (2017).
Articles published as they become available and compiled into annual volumes.
Also issued online.